Lower FASN protein levels, a central lipogenesis enzyme that catalyses de novo saturated FA biosynthesis, has been associated with hyperglycaemia, insulin resistance and obesity (Mayas et al., 2010). The gene discussed is FASN; the disease is obesity disorder.